gene silencing

The shares of Benitec Biopharma Inc (NASDAQ: BNTC) are trading 92.5% higher at $6.14 in the early pre-market session on Tuesday.  What Happened: Benitec shares had closed at $3.19 on Monday. The surge follows Morgan Stanley (NYSE: MS) disclosing in a filing with the U.S. Securities and...

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) develops medicines to treat intractable diseases. The company’s therapies trigger the RNA interference to alter target genes, as a natural process of gene silencing. What Happened Arrowhead announced entrance into a $3.7-billion license and...